Literature DB >> 2685453

[Status of the captopril test in the diagnosis of hypertension].

S Degenhardt1, H Friedrich, G Wambach, J H Fischer, W Gross-Fengels, A Linden, K F Neufang, W Hummerich.   

Abstract

The place of captopril (C) testing in the screening for renovascular hypertension is still controversial. Baseline and C-stimulated plasma renin concentrations (PRC) were measured in 113 hypertensives, who where referred for the exclusion of secondary hypertension. In addition intravenous digital subtraction angiography (DSA) and a renal scintigraphy were performed. When renal artery disease was revealed by DSA or renin was stimulated the renal arteries were visualized by direct arteriography (and treated by angioplasty if possible). 86 patients underwent each diagnostic test: 21% had renovascular hypertension. Unilateral renal artery stenosis (n = 10) was detected by the captopril test (cutoff values: baseline greater than 40 microU/ml, after C greater than 180 microU/ml, sensitivity 100%). Bilateral renal artery stenosis (n = 8) was missed when the disease was equally severe on either side (sensitivity 50%). The specificity of C testing was 82%, overall sensitivity (uni- and bilateral disease 78%, prevalence 21%, predictive value of the positive test 0.56, predictive value of the negative test 0.93). With i.v.-DSA the renal arteries were technically evaluable in 91% (82/92) of cases. The sensitivity for the detection of all renal artery stenoses was 79% (uni-lateral 100%, bilateral 40%, specificity 97%). The sensitivity of renal scintigraphy for the detection of unilateral renal artery stenoses was 50%, for the detection of bilateral renal artery stenoses 43%, specificity 81%. The present study demonstrates the usefulness of captopril for the detection of unilateral renal artery stenosis.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2685453     DOI: 10.1007/bf01741782

Source DB:  PubMed          Journal:  Klin Wochenschr        ISSN: 0023-2173


  28 in total

1.  The captopril challenge test as a screening test for renovascular hypertension.

Authors:  A Idrissi; A Fournier; H Renaud; B Boudailliez; N el Esper; P Fievet; P F Westeel; R Makdassi; A Remond
Journal:  Kidney Int Suppl       Date:  1988-09       Impact factor: 10.545

2.  [Diagnosis of renovascular hypertension using venous DSA (digital subtraction angiography): image quality and predictive value 1987. Determination of current status].

Authors:  K F Neufang; S Degenhardt; U Mödder
Journal:  Rofo       Date:  1987-09

3.  Arterial pressure regulation. Overriding dominance of the kidneys in long-term regulation and in hypertension.

Authors:  A C Guyton; T G Coleman; A V Cowley; K W Scheel; R D Manning; R A Norman
Journal:  Am J Med       Date:  1972-05       Impact factor: 4.965

Review 4.  Renovascular hypertension.

Authors:  C V Ram
Journal:  Cardiol Clin       Date:  1988-11       Impact factor: 2.213

5.  Prevalence of primary and secondary hypertension: studies in a random population sample.

Authors:  G Berglund; O Andersson; L Wilhelmsen
Journal:  Br Med J       Date:  1976-09-04

6.  The captopril test for identifying renovascular disease in hypertensive patients.

Authors:  F B Muller; J E Sealey; D B Case; S A Atlas; T G Pickering; M S Pecker; J J Preibisz; J H Laragh
Journal:  Am J Med       Date:  1986-04       Impact factor: 4.965

7.  Renovascular hypertension identified by captopril-induced changes in the renogram.

Authors:  G G Geyskes; H Y Oei; C B Puylaert; E J Mees
Journal:  Hypertension       Date:  1987-05       Impact factor: 10.190

8.  Captopril test in the detection of renovascular hypertension in a population with low prevalence of the disease. A prospective study.

Authors:  P Gosse; J Y Dupas; P Reynaud; E Jullien; M Dallocchio
Journal:  Am J Hypertens       Date:  1989-03       Impact factor: 2.689

9.  Percutaneous transluminal renal angioplasty in the patient with a solitary functioning kidney.

Authors:  D N McDonald; D C Smith; M D Maloney
Journal:  AJR Am J Roentgenol       Date:  1988-11       Impact factor: 3.959

10.  [Primary and secondary hypertension in polyclinical patients].

Authors:  P Greminger; W Vetter; K Zimmermann; R Beckerhoff; W Siegenthaler
Journal:  Schweiz Med Wochenschr       Date:  1977-04-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.